BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35499353)

  • 1. Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System
    Spaggiari L; Sala A; Ardizzoni A; De Seta F; Singh DK; Gacser A; Blasi E; Pericolini E
    Microbiol Spectr; 2022 Jun; 10(3):e0269621. PubMed ID: 35499353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
    Vicariotto F; Del Piano M; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
    Martinez RC; Seney SL; Summers KL; Nomizo A; De Martinis EC; Reid G
    Microbiol Immunol; 2009 Sep; 53(9):487-95. PubMed ID: 19703242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of vaginal
    Takano T; Kudo H; Eguchi S; Matsumoto A; Oka K; Yamasaki Y; Takahashi M; Koshikawa T; Takemura H; Yamagishi Y; Mikamo H; Kunishima H
    Front Cell Infect Microbiol; 2023; 13():1113401. PubMed ID: 37201113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals.
    Paniágua AL; Correia AF; Pereira LC; de Alencar BM; Silva FBA; Almeida RM; de Medeiros Nóbrega YK
    BMC Complement Med Ther; 2021 Sep; 21(1):237. PubMed ID: 34556109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period.
    Intra J; Sala MR; Brambilla P; Carcione D; Leoni V
    J Mycol Med; 2022 Aug; 32(3):101278. PubMed ID: 35523109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilms and vulvovaginal candidiasis.
    Rodríguez-Cerdeira C; Gregorio MC; Molares-Vila A; López-Barcenas A; Fabbrocini G; Bardhi B; Sinani A; Sánchez-Blanco E; Arenas-Guzmán R; Hernandez-Castro R
    Colloids Surf B Biointerfaces; 2019 Feb; 174():110-125. PubMed ID: 30447520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limosilactobacillus reuteri 29A Cell-Free Supernatant Antibiofilm and Antagonistic Effects in Murine Model of Vulvovaginal Candidiasis.
    Boahen A; Chew SY; Neela VK; Than LTL
    Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1681-1699. PubMed ID: 36881331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Phenotype in
    Sala A; Ardizzoni A; Spaggiari L; Vaidya N; van der Schaaf J; Rizzato C; Cermelli C; Mogavero S; Krüger T; Himmel M; Kniemeyer O; Brakhage AA; King BL; Lupetti A; Comar M; de Seta F; Tavanti A; Blasi E; Wheeler RT; Pericolini E
    mBio; 2023 Apr; 14(2):e0010723. PubMed ID: 36856418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis.
    Ebrahimi-Shaghaghi F; Atyabi SM; Razzaghi-Abyaneh M
    Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34694384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis.
    Zhu Y; Shan Y; Fan S; Li J; Liu X
    Mycopathologia; 2015 Feb; 179(1-2):111-8. PubMed ID: 25322705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
    De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis.
    Chen Z; Jin J; Chen H; Chen Y; Feng S
    Microb Pathog; 2023 Apr; 177():106037. PubMed ID: 36842517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study.
    Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.
    De Gregorio PR; Parolin C; Abruzzo A; Luppi B; Protti M; Mercolini L; Silva JA; Giordani B; Marangoni A; Nader-Macías MEF; Vitali B
    Microb Cell Fact; 2020 Jun; 19(1):133. PubMed ID: 32552788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the therapeutic potentials of
    ElFeky DS; Awad AR; Shamseldeen AM; Mowafy HL; Hosny SA
    Front Microbiol; 2023; 14():1222503. PubMed ID: 37529322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
    Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
    Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.